Two Sigma Securities’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Two Sigma Securities’s Portfolio BIOR Stock Details BIOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,679	Closed	-$8.42K	–	3520
2024 Q3	$8.42K	Sell	1,679 -4,949	-75%	-$32.1K	﹤0.01%	2622
2024 Q2	$43.7K	Buy	+6,628	New	+$45.1K	﹤0.01%	2585
2023 Q1	–	Sell	-356	Closed	-$11.7K	–	3507
2022 Q4	$11.7K	Buy	+356	New	+$26K	﹤0.01%	2338
2022 Q1	–	Sell	-58	Closed	-$30K	–	2665
2021 Q4	$30K	Sell	58 -18	-24%	-$12.9K	﹤0.01%	1360
2021 Q3	$29K	Sell	76 -127	-63%	-$54.5K	﹤0.01%	1437
2021 Q2	$181K	Buy	+203	New	+$155K	0.01%	1302

Two Sigma Securities's BIOR Position: Q4 2024 in Review

Two Sigma Securities sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2024, closing a stake of 1,679 shares — an estimated $8.42K sold.

Two Sigma Securities first reported a position in BIOR in Q2 2021 and held it in 6 quarters. The position peaked at $181K in Q2 2021. 0 funds tracked by Wall St. Rank hold BIOR as of Q4 2024.

Two Sigma Securities reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Two Sigma Securities sold 1,679 Biora Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $8.42K.
Two Sigma Securities first reported a position in Biora Therapeutics, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Two Sigma Securities's Biora Therapeutics, Inc. Common Stock position peaked at $181K in Q2 2021.
0 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.